Delivery Order SPE2DE24D0013-SPE2D626F436M

Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $4,080 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for the detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a routine procurement of diagnostic testing supplies to support federal healthcare operations. The performance location is Cepheid's primary facility in Sunnyvale, California.

This delivery order reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions across multiple defense and civilian healthcare agencies. As a manufacturer of advanced diagnostic systems and reagents, Cepheid has built an extensive portfolio of federal contracts with the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and Defense Logistics Agency. The company's core GeneXpert diagnostic platform and associated testing capabilities have proven essential to federal infectious disease testing programs, with the company maintaining multiple indefinite delivery contracts valued in the tens of millions of dollars that extend through 2029 and 2030. This modest delivery order exemplifies the ongoing, demand-driven procurement of testing supplies that flows from these larger contracting vehicles.